Possible role of a radiation-induced p53 mutation in a Nelson's syndrome patient with a fatal outcome
Carregando...
Citações na Scopus
18
Tipo de produção
article
Data de publicação
2011
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER
Citação
PITUITARY, v.14, n.4, p.400-404, 2011
Resumo
Nelson's syndrome (NS) is characterized by the appearance and/or progression of ACTH-secreting pituitary macroadenomas in patients who had previously undergone bilateral adrenalectomy for the treatment of Cushing's disease. Such corticotroph macroadenomas respond poorly to currently available therapeutic options which include surgery, radiotherapy and chemotherapy. P53 protein accumulation may be detected by immunohistochemistry in pituitary corticotroph adenomas and it has been suggested that it might be causally related to tumor development. Wild type P53 protein plays an important role in the cellular response to ionizing radiation and other DNA damaging agents and is mutated in many human tumors. In this study we report an adult male patient with NS who underwent both transsphenoidal and transcranial pituitary surgeries, conventional and stereotaxic radiotherapy and brachytherapy. Despite of the efforts to control tumor mass and growth, this macroadenoma displayed relentless growth and aggressive behavior. DNA extracted from the first two surgical samples, as well as DNA from peripheral blood leukocytes disclosed normal p53 sequence. DNA extracted from tumor samples obtained at surgeries performed after pituitary irradiation carried a somatic heterozygous mutation, consisting of a deletion of four cytosines between nucleotides 12,144-12,149 in exon 4 of the p53 gene. This frameshift mutation creates a stop codon in exon 4 excluding the expression of a functional protein from the defective allele. These data demonstrate a possible association between the P53 protein loss of function induced by radiotherapy and the aggressive course of the disease in this patient.
Palavras-chave
p53, Nelson's syndrome, ACTH-secreting pituitary adenomas, Radiotherapy
Referências
- Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675
- Assie G, 2007, J CLIN ENDOCR METAB, V92, P172, DOI 10.1210/jc.2006-1328
- Pereira MAA, 1998, CLIN ENDOCRINOL, V49, P533, DOI 10.1046/j.1365-2265.1998.00578.x
- Karl M, 1996, J CLIN ENDOCR METAB, V81, P124, DOI 10.1210/jc.81.1.124
- Kawashima ST, 2009, CLIN ENDOCRINOL, V70, P656, DOI 10.1111/j.1365-2265.2008.03404.x
- BATES AS, 1995, CLIN ENDOCRINOL, V42, P663, DOI 10.1111/j.1365-2265.1995.tb02697.x
- Bates AS, 1995, CLIN ENDOCRINOL OXF, V42, P671
- BUCKLEY N, 1995, J CLIN ENDOCR METAB, V80, P692
- Kontogeorgos G, 1999, Pituitary, V1, P207, DOI 10.1023/A:1009929704018
- KOUHARA H, 1992, ENDOCRINOL JAPON, V39, P177
- LANE DP, 1994, PHILOS T ROY SOC B, V345, P277, DOI 10.1098/rstb.1994.0106
- LEVY A, 1994, CLIN ENDOCRINOL, V41, P809, DOI 10.1111/j.1365-2265.1994.tb02797.x
- Machado ALO, 2005, J ENDOCRINOL INVEST, V28, P795
- Munir A, 2007, ARQ BRAS ENDOCRINOL, V51, P1392, DOI 10.1590/S0004-27302007000800026
- Oliveira MC, 2002, BRAZ J MED BIOL RES, V35, P561, DOI 10.1590/S0100-879X2002000500008
- RUPP GM, 1988, BIOTECHNIQUES, V6, P56
Coleções
Artigos e Materiais de Revistas Científicas - FM/MPT
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/14
Artigos e Materiais de Revistas Científicas - LIM/22
Carregar mais Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/14
Artigos e Materiais de Revistas Científicas - LIM/22